Literature DB >> 25805644

Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.

Candice Chapouly1, Azeb Tadesse Argaw1, Sam Horng1, Kamilah Castro1, Jingya Zhang1, Linnea Asp1, Hannah Loo1, Benjamin M Laitman1, John N Mariani1, Rebecca Straus Farber1, Elena Zaslavsky2, German Nudelman2, Cedric S Raine3, Gareth R John4.   

Abstract

In inflammatory central nervous system conditions such as multiple sclerosis, breakdown of the blood-brain barrier is a key event in lesion pathogenesis, predisposing to oedema, excitotoxicity, and ingress of plasma proteins and inflammatory cells. Recently, we showed that reactive astrocytes drive blood-brain barrier opening, via production of vascular endothelial growth factor A (VEGFA). Here, we now identify thymidine phosphorylase (TYMP; previously known as endothelial cell growth factor 1, ECGF1) as a second key astrocyte-derived permeability factor, which interacts with VEGFA to induce blood-brain barrier disruption. The two are co-induced NFκB1-dependently in human astrocytes by the cytokine interleukin 1 beta (IL1B), and inactivation of Vegfa in vivo potentiates TYMP induction. In human central nervous system microvascular endothelial cells, VEGFA and the TYMP product 2-deoxy-d-ribose cooperatively repress tight junction proteins, driving permeability. Notably, this response represents part of a wider pattern of endothelial plasticity: 2-deoxy-d-ribose and VEGFA produce transcriptional programs encompassing angiogenic and permeability genes, and together regulate a third unique cohort. Functionally, each promotes proliferation and viability, and they cooperatively drive motility and angiogenesis. Importantly, introduction of either into mouse cortex promotes blood-brain barrier breakdown, and together they induce severe barrier disruption. In the multiple sclerosis model experimental autoimmune encephalitis, TYMP and VEGFA co-localize to reactive astrocytes, and correlate with blood-brain barrier permeability. Critically, blockade of either reduces neurologic deficit, blood-brain barrier disruption and pathology, and inhibiting both in combination enhances tissue preservation. Suggesting importance in human disease, TYMP and VEGFA both localize to reactive astrocytes in multiple sclerosis lesion samples. Collectively, these data identify TYMP as an astrocyte-derived permeability factor, and suggest TYMP and VEGFA together promote blood-brain barrier breakdown.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  astrocyte; blood–brain barrier; endothelial cell growth factor; endothelium; tight junction

Mesh:

Substances:

Year:  2015        PMID: 25805644      PMCID: PMC4614128          DOI: 10.1093/brain/awv077

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  108 in total

1.  The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.

Authors:  Jorge Ivan Alvarez; Aurore Dodelet-Devillers; Hania Kebir; Igal Ifergan; Pierre J Fabre; Simone Terouz; Mike Sabbagh; Karolina Wosik; Lyne Bourbonnière; Monique Bernard; Jack van Horssen; Helga E de Vries; Frédéric Charron; Alexandre Prat
Journal:  Science       Date:  2011-12-01       Impact factor: 47.728

2.  Pericytes regulate the blood-brain barrier.

Authors:  Annika Armulik; Guillem Genové; Maarja Mäe; Maya H Nisancioglu; Elisabet Wallgard; Colin Niaudet; Liqun He; Jenny Norlin; Per Lindblom; Karin Strittmatter; Bengt R Johansson; Christer Betsholtz
Journal:  Nature       Date:  2010-10-13       Impact factor: 49.962

Review 3.  Mitochondrial syndromes with leukoencephalopathies.

Authors:  Lee-Jun C Wong
Journal:  Semin Neurol       Date:  2012-03-15       Impact factor: 3.420

4.  Sera from neuromyelitis optica patients disrupt the blood-brain barrier.

Authors:  Fumitaka Shimizu; Yasuteru Sano; Toshiyuki Takahashi; Hiroyo Haruki; Kazuyuki Saito; Michiaki Koga; Takashi Kanda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-11-19       Impact factor: 10.154

5.  Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier.

Authors:  Takafumi Hosokawa; Hideto Nakajima; Yoshimitsu Doi; Masakazu Sugino; Fumiharu Kimura; Toshiaki Hanafusa; Toshiyuki Takahashi
Journal:  J Neuroimmunol       Date:  2011-05-31       Impact factor: 3.478

6.  GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain.

Authors:  A Denise R Garcia; Ngan B Doan; Tetsuya Imura; Toby G Bush; Michael V Sofroniew
Journal:  Nat Neurosci       Date:  2004-10-24       Impact factor: 24.884

7.  Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase.

Authors:  Shunichi Tsujitani; Hiroaki Saito; Yoshihiko Maeta; Kenichi Yamaguchi; Shigeru Tatebe; Akira Kondo; Nobuaki Kaibara
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

Review 8.  Complex role of heme oxygenase-1 in angiogenesis.

Authors:  Józef Dulak; Agnieszka Łoboda; Anna Zagórska; Alicja Józkowicz
Journal:  Antioxid Redox Signal       Date:  2004-10       Impact factor: 8.401

9.  A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.

Authors:  H J Schluesener; R A Sobel; C Linington; H L Weiner
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

10.  Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors.

Authors:  I V Bijnsdorp; F Capriotti; F A E Kruyt; N Losekoot; M Fukushima; A W Griffioen; V L Thijssen; G J Peters
Journal:  Br J Cancer       Date:  2011-03-08       Impact factor: 7.640

View more
  55 in total

Review 1.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

2.  Balanced single-vector co-delivery of VEGF/PDGF-BB improves functional collateralization in chronic cerebral ischemia.

Authors:  Aiki Marushima; Melina Nieminen; Irina Kremenetskaia; Roberto Gianni-Barrera; Johannes Woitzik; Georges von Degenfeld; Andrea Banfi; Peter Vajkoczy; Nils Hecht
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-09       Impact factor: 6.200

3.  Glutaric Acid Affects Pericyte Contractility and Migration: Possible Implications for GA-I Pathogenesis.

Authors:  Eugenia Isasi; Nils Korte; Verónica Abudara; David Attwell; Silvia Olivera-Bravo
Journal:  Mol Neurobiol       Date:  2019-05-18       Impact factor: 5.590

4.  Astrocytic tight junctions control inflammatory CNS lesion pathogenesis.

Authors:  Sam Horng; Anthony Therattil; Sarah Moyon; Alexandra Gordon; Karla Kim; Azeb Tadesse Argaw; Yuko Hara; John N Mariani; Setsu Sawai; Per Flodby; Edward D Crandall; Zea Borok; Michael V Sofroniew; Candice Chapouly; Gareth R John
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 5.  Connexin Channels at the Glio-Vascular Interface: Gatekeepers of the Brain.

Authors:  Marijke De Bock; Luc Leybaert; Christian Giaume
Journal:  Neurochem Res       Date:  2017-06-20       Impact factor: 3.996

6.  Genetic variants and cognitive functions in patients with brain tumors.

Authors:  Denise D Correa; Jaya Satagopan; Axel Martin; Erica Braun; Maria Kryza-Lacombe; Kenneth Cheung; Ajay Sharma; Sofia Dimitriadoy; Kelli O'Connell; Siok Leong; Sasan Karimi; John Lyo; Lisa M DeAngelis; Irene Orlow
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

Review 7.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

8.  Leukemia-derived exosomes and cytokines pave the way for entry into the brain.

Authors:  Ichiko Kinjyo; Denis Bragin; Rachel Grattan; Stuart S Winter; Bridget S Wilson
Journal:  J Leukoc Biol       Date:  2019-01-31       Impact factor: 4.962

Review 9.  Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis.

Authors:  Hui Liu; Ke Qiu; Qiang He; Qiang Lei; Wei Lu
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-19       Impact factor: 4.147

Review 10.  Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.

Authors:  Luc Bertrand; Madhavan Nair; Michal Toborek
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.